Print Page

Products found to contain undeclared medicines

United States : Public Notification: PAYA Dietary Supplement Product contains hidden drug ingredient
The Food and Drug Administration (FDA) is advising consumers not to purchase or use PAYA Dietary Supplement Product, a product promoted for weight loss. This product was identified by FDA during an examination of international mail shipments.

FDA laboratory analysis confirmed that PAYA Dietary Supplement Product contains sibutramine. Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons.

This product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or heart rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.

Please refer to the following website in FDA for details:

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/ Friday , June 8, 2018
Issued at HKT 17:45